Company / Operating Income per Share
InMed Pharmaceuticals Inc. Operating Income per Share History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$28.59
FY2023
5-year range
-$31.68 / -$28.59
FY2022-FY2023
Trend
+9.8%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-28.59 in FY2023.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, operating income per share increased 9.8% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -$28.59 | +9.8% |
| FY2022 | -$31.68 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026